SharesGrow.com S&P・Nasdaq 本質的価値お問い合わせ

हिन्दी

← 全銘柄に戻る

Structure Therapeutics Inc. GPCR NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Structure Therapeutics Inc. (GPCR) には 12 社の同業他社が比較対象として特定されています Healthcare セクター. 同業他社には ABOS, AMLX, BMEA, DAWN, DICE, ELDN など.

GPCR の時価総額は $3.12B, 同業他社の平均時価総額と比較して $1.42B. GPCR 平均的な同業他社より大幅に大きい.

同業・類似企業 — GPCR

Acumen Pharmaceuticals, Inc.

$2.72 +1.49% $164.76M

Amylyx Pharmaceuticals, Inc.

$17.12 +1.18% $1.42B

Biomea Fusion, Inc.

$1.97 +1.03% $117.21M

Day One Biopharmaceuticals, Inc.

$21.47 +0.05% $2.22B

DICE Therapeutics, Inc.

$47.55 +0.06% $2.27B

Eledon Pharmaceuticals, Inc.

$3.30 +3.13% $197.83M

HOOKIPA Pharma Inc.

$1.11 -1.34% $13.83M

Inozyme Pharma, Inc.

$4.00 +0.25% $258.25M

Disc Medicine, Inc.

$70.18 -0.43% $2.68B

Morphic Holding, Inc.

$56.99 +0.04% $2.86B

Mereo BioPharma Group plc

$0.34 +2.98% $54.08M

Terns Pharmaceuticals, Inc.

$52.71 +0.06% $4.75B

他のユーザーも閲覧

Terns Pharmaceuticals, Inc.

Morphic Holding, Inc.

Disc Medicine, Inc.

DICE Therapeutics, Inc.

Day One Biopharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc.

Inozyme Pharma, Inc.

Eledon Pharmaceuticals, Inc.

お問い合わせ

🎓

SharesGrow アカデミー

本質的価値の計算と割安株の見つけ方を学ぶ。

毎週のライブセッション

📧 [email protected]

📞 +65 8912 8000

メッセージを送る